New data suggests that patients were satisfied with their cosmetic outcomes following the removal of suspicious tissue detected by fluorescence-guided imaging during lumpectomy surgery, and prefer ...

Poster Discussion Session: Poster Board #1404 Date and time: Tuesday, May 20, 2025 from 11:30 a.m. – 1:15 p.m. PT Presenting Author: Rajan Saggar, MD Abstract: An ASCENT to Week 8: Initial ...

GOLDEN, Colo., November 12, 2024--PharmaJet needle-free technology enhances mRNA vaccine immune response and has been successfully adopted into multiple vaccine development programs.

The two posters will be available on the A2 Bio website after November 4, 2023. About A2B530 A2B530 consists of an activator that targets carcinoembryonic antigen (CEA) and a blocker that targets ...

The poster presentation describes preliminary findings from the company’s Phase 1a study of HFK1 for HER2 low expression cancers. The first patient dosed suffers from lung metastasis of a rare ...